You are on page 1of 1

Federal Register / Vol. 70, No.

44 / Tuesday, March 8, 2005 / Notices 11245

1. Exchange National Bancshares, DEPARTMENT OF HEALTH AND FOR FURTHER INFORMATION CONTACT: Dr.
Inc., Jefferson City, Missouri; to acquire HUMAN SERVICES Scott R. Smith, Center for Outcomes and
100 percent of the voting shares of Bank Evidence, Agency for Healthcare
10, Belton, Missouri. Agency for Healthcare Research and Research and Quality, 540 Gaither Road,
Quality Rockville, MD 20850, Phone: (301) 427–
2. First National Security Company,
1511, Fax: (301) 427–1520, E-mail:
DeQueen, Arkansas; to acquire 100 Limited Competition for Supplemental ssmith@ahrq.gov.
percent of the voting shares of First Grants for Centers for Education and
Community Banking Corporation, Hot Research (CERTs) SUPPLEMENTARY INFORMATION:
Springs, Arkansas, and thereby Background
indirectly acquire First National Bank, AGENCY: Agency for Healthcare Research
Hot Springs, Arkansas; First National and Quality, HHS. Section 1013 of the MMA directs the
Bank in Mena, Mena, Arkansas; and ACTION: Notice of availability of fund for Secretary of the Department of health
limited competitive supplements. and Human Services (DHHS), acting
First National Bank, Mount Ida,
through the Director of AHRQ, to
Arkansas.
SUMMARY: This notice informs the support research to address priorities
Board of Governors of the Federal Reserve research community that the Agency for identified by the Medicare, Medicaid,
System, March 2, 2005. Healthcare Research and Quality and SCHIP programs and other
Robert deV. Frierson, (AHRQ) is requesting applications for concerned stakeholders, regarding
Deputy Secretary of the Board. competitive supplemental grants from improvement of health care outcomes,
[FR Doc. 05–4456 Filed 3–7–05; 8:45 am] the seven Centers for Education and comparative clinical effectiveness, and
Research on Therapeutics (CERTs) for appropriateness of health care items and
BILLING CODE 6210–01–P
which it provided funding in fiscal year services (including prescription drugs)
2004. either provided or possibly not
FEDERAL RESERVE SYSTEM The purpose of the competitive currently covered under these programs;
supplements is to provide funds for and strategies for improving program
Federal Open Market Committee; existing CERTs research centers to build efficiency and effectiveness with
Domestic Policy Directive of February on and to expand their research work attention to the ways in which health
1-2, 2005 and expertise with respect to care items and services are organized,
comparative effectiveness research managed, and delivered under these
In accordance with § 271.25 of its specifically to carry out short term programs.
rules regarding availability of projects that will address research gaps Pursuant to this section 1013, which
information (12 CFR part 271), there is in priority subject areas identified and may also be found at 42 U.S.C. 229b–7,
set forth below the domestic policy published pursuant to section 1013 of DHHS published, on December 15,
the Medicare Prescription Drug, 2004, an initial priority list of ten
directive issued by the Federal Open
Improvement, and Modernization Act conditions with respect to which
Market Committee at its meeting held
(MMA). Since the inception of the research mandated under this section is
on February 1-2, 2005.1 to be promptly undertaken. The ten
CERTs program in 1999, the CERTs
The Federal Open Market Committee research centers have gathered conditions are:
seeks monetary and financial conditions significant data regarding therapeutics, • Ischemic heart disease
that will foster price stability and refined research methodologies, and • Cancer
promote sustainable growth in output. developed collaborative research • Chronic obstructive pulmonary
To further its long–run objectives, the resources. They are therefore uniquely disease/asthma
Committee in the immediate future prepared and suited to efficiently carry • Stroke, including control of
seeks conditions in reserve markets out pharmaco-epidemiology and hypertension
consistent with increasing the federal methodological studies related to • Arthritis and non-traumatic joint
funds rate to an average of around 2-1/ comparative effectiveness research that disorders
2 percent. is pertinent to developing therapeutic • Diabetes mellitus
evidence identified as being of high • Dementia, including Alzheimer’s
By order of the Federal Open Market disease
Committee, February 28, 2005. interest to the Medicare, Medicaid or
SCHIP programs. For this reason, this • Pneumonia
Vincent R. Reinhart, solicitation will be for a limited • Peptic ulcer/dyspepsia
Secretary, Federal Open Market Committee. competition among CERTs grantees. • Depression and other mood
disorders
[FR Doc. 05–4455 Field 3–7–05; 8:45 am] DATES: The receipt date for the
The Centers for Education and
BILLING CODE 6210–01–S competitive supplemental grant
Research on Therapeutics (CERTs)
applications is April 7, 2005. AHRQ
program was first developed by AHRQ
will inform the current grantees directly
in accordance with a Congressional
regarding application procedures and
authorization in the Food and Drug
format.
Administration Modernization Act of
ADDRESSES: Submission of the 1997 (Pub. L. 105–115) to carry out or
applications should be sent to: Dr. support research that would provide
1 Copies of the Minutes of the Federal Open
Gerald Calderone, Office of Extramural objective information on drugs,
Market Committee meeting on February 1-2, 2005, Research, Education, and Priority biologics, and medical devices. Just
which includes the domestic policy directive issued
Populations, Agency for Healthcare months after the first CERTs grants were
at the meeting, are available upon request to the
Board of Governors of the Federal Reserve System, Research and Quality, 540 Gaither Road, awarded, the CERTs program was
Washington, D.C. 20551. The minutes are published Rockville, MD 20850, Phone: (301) 427– incorporated into the AHRQ
in the Federal Reserve Bulletin and in the Board’s 1548, Fax: (301) 427–1561, E-mail: Reauthorization Act of 1999 (Pub. L.
annual report. gcaldero@ahrq.gov. 106–129); its objectives: to increase

VerDate jul<14>2003 19:54 Mar 07, 2005 Jkt 205001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\08MRN1.SGM 08MRN1

You might also like